VeriSeq™ NIPT: The New Standard in Prenatal Screening

2018年5月17日

If you think noninvasive prenatal testing (NIPT) is too complicated, think again. Discover VeriSeq NIPT, a different approach from Illumina. Built on industry-leading technology, the solution is simple, fast, and automated. Transform your lab with the revolutionary workflow.

For In Vitro Diagnostic Use. Not available in all countries and regions. Subscribe to the Illumina video channel. A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2017.

View customer spotlight videos

View Illumina webinars

View Illumina product videos

View Illumina support videos

この記事を共有します